Cargando…
Pharmacovigilance for clinical trials in India: Current practice and areas for reform
Keeping in mind India’s increasing participation in multinational trials, this article explores potential areas of Indian pharmacovigilance, requiring reform and provides recommendations for building a robust safety reporting system. Internal discrepancies exist between Schedule Y and Central Drugs...
Autores principales: | Brahmachari, Ballari, Fernandes, Melanie, Bhatt, Arun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121263/ https://www.ncbi.nlm.nih.gov/pubmed/21731854 http://dx.doi.org/10.4103/2229-3485.80366 |
Ejemplares similares
-
A day in the life of a pharmacovigilance case processor
por: Bhangale, Ritesh, et al.
Publicado: (2017) -
Global research output in ‘pharmacovigilance’ during 2010–2020
por: Tyagi, Sunil
Publicado: (2022) -
Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022
por: Bihan, Kevin, et al.
Publicado: (2023) -
Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2023) -
French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
por: de Canecaude, Claire, et al.
Publicado: (2023)